CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The BARCODE project aims to improve prostate cancer screening and treatment by profiling genetic variants in populations. It seeks to identify patients needing more intensive care based on genetic predispositions.
Prostate cancer is the commonest solid cancer in men in the European Community.
There is evidence for genetic predisposition to the development of prostate cancer and our group has found the largest number of such genetic variants described to date worldwide.
The next challenge is to harness these discoveries to advance the clinical care of populations and prostate cancer patients to improve screening and target treatments.
This proposal, BARCODE, aims to be ground-breaking in this area. BARCODE…
INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
